Celine Chabanne
Overview
Explore the profile of Celine Chabanne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
611
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anselmi A, Daniel M, Aymami M, Chabanne C, Rosier S, Mancini J, et al.
Thorac Cardiovasc Surg
. 2025 Jan;
PMID: 39777629
Background: The long-term comparative results between porcine and pericardial bioprostheses for surgical aortic valve replacement (SAVR) are debated. Scarce information exists concerning direct comparative evaluation among contemporary devices. We compared...
2.
Le Gac G, Mansour A, Labory M, Flecher E, Chabanne C, Ecoffey C, et al.
Br J Anaesth
. 2024 Jun;
133(2):450-452.
PMID: 38834488
No abstract available.
3.
Baudry G, Coutance G, Dorent R, Bauer F, Blanchart K, Boignard A, et al.
ESC Heart Fail
. 2023 Jul;
10(5):2843-2852.
PMID: 37408178
Aims: The prognostic value of 'high dose' loop diuretics in advanced heart failure outpatients is unclear. We aimed to assess the prognosis associated with loop diuretic dose in ambulatory patients...
4.
Chaigne B, Chevalier K, Boucly A, Agard C, Baudet A, Bourdin A, et al.
Rheumatology (Oxford)
. 2023 Feb;
62(10):3261-3267.
PMID: 36727465
Objective: Pulmonary arterial hypertension (PAH) is a leading cause of death in MCTD. We aimed to describe PAH in well-characterized MCTD patients. Methods: MCTD patients enrolled in the French Pulmonary...
5.
Coste G, Chabanne C, Tron C, Lelong B, Verdier M, Roussel M, et al.
Ther Drug Monit
. 2022 Aug;
45(2):229-235.
PMID: 36006706
Background: After heart transplantation, calcineurin inhibitors (CNI) (cyclosporin A and tacrolimus) are key immunosuppressive drugs to prevent graft rejection. Whole-blood concentration (C blood )-guided therapeutic drug monitoring (TDM) is systematically...
6.
Jais X, Brenot P, Bouvaist H, Jevnikar M, Canuet M, Chabanne C, et al.
Lancet Respir Med
. 2022 Aug;
10(10):961-971.
PMID: 35926542
Background: Riociguat and balloon pulmonary angioplasty (BPA) are treatment options for inoperable chronic thromboembolic pulmonary hypertension (CTEPH). However, randomised controlled trials comparing these treatments are lacking. We aimed to evaluate...
7.
Baudry G, Coutance G, Dorent R, Bauer F, Blanchart K, Boignard A, et al.
ESC Heart Fail
. 2022 Jul;
9(5):3287-3297.
PMID: 35801277
Aims: The value of Forrester's perfusion/congestion profiles assessed by invasive catheter evaluation in non-inotrope advanced heart failure patients listed for heart transplant (HT) is unclear. We aimed to assess the...
8.
Coirier V, Chabanne C, Jouneau S, Belhomme N, Ballerie A, Cazalets C, et al.
Diagnostics (Basel)
. 2021 Oct;
11(10).
PMID: 34679436
Background: to compare three existing screening algorithms of pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) with the results of a multidisciplinary team (MDT) meeting from a tertiary center. Methods:...
9.
Boucly A, Savale L, Jais X, Bauer F, Bergot E, Bertoletti L, et al.
Am J Respir Crit Care Med
. 2021 Jun;
204(7):842-854.
PMID: 34185620
The relationship between the initial treatment strategy and survival in pulmonary arterial hypertension (PAH) remains uncertain. To evaluate the long-term survival of patients with PAH categorized according to the initial...
10.
Thore P, Jais X, Savale L, Dorfmuller P, Boucly A, Devilder M, et al.
J Clin Immunol
. 2021 Jun;
41(7):1549-1562.
PMID: 34110542
Purpose: Common variable immunodeficiency (CVID) is known to cause infectious, inflammatory, and autoimmune manifestations. Pulmonary hypertension (PH) is an unusual complication of CVID with largely unknown characteristics and mechanisms. Methods:...